 GAITHERSBURG, Md., March 01, 2021 GLOBE NEWSWIRE -- Viela Bio Nasdaq:VIE, a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today reported financial results and provided program and business highlights for the fourth quarter and full year ended December 31, 2020. 